Last updated: August 26. 2013 12:36PM - 956 Views
Associated Press



In this Aug. 19, 2013, photo, stock traders work at the Goldman Sachs post at the New York Stock Exchange in New York.  U.S. stock futures were mixed on data showing that businesses cut back sharply on big-ticket purchases last month. The report from the Commerce Department Monday, Aug. 26, 2013, followed a report Friday revealing that new home sales tumbled last month. (AP Photo/Mark Lennihan)
In this Aug. 19, 2013, photo, stock traders work at the Goldman Sachs post at the New York Stock Exchange in New York. U.S. stock futures were mixed on data showing that businesses cut back sharply on big-ticket purchases last month. The report from the Commerce Department Monday, Aug. 26, 2013, followed a report Friday revealing that new home sales tumbled last month. (AP Photo/Mark Lennihan)
Story Tools:

Font Size:

Social Media:

(AP) A handful of corporate deals helped nudge the stock market higher despite a disappointing report on the economy.


Amgen surged after the biotech giant said it plans to buy Onyx Pharmaceuticals for $10.4 billion. The deal would give Amgen three approved cancer treatments and several others in clinical trials.


The Standard & Poor's 500 index rose four points, or 0.3 percent, to 1,667 as of noon Monday.


The Dow Jones industrial average rose 24 points, or 0.2 percent, to 15,034. The Nasdaq composite rose 21 points, or 0.6 percent, at 3,679.


Orders for long-lasting manufactured goods plunged 7.3 percent last month, the steepest drop in nearly a year.


Amgen gained $9.64, or 9 percent, to $115.29. Onyx rose $6.62, or 6 percent, to $123.58.


Associated Press
Comments
comments powered by Disqus


Featured Businesses


Poll



Mortgage Minute